Related Experiment Video
Updated: Aug 5, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and
Mairéad Gallagher1, Lyuboslava G Harkova2, Dominika Krawiel2
1Centre for AMR and One Health Research, TU Dublin Tallaght Campus, Dublin, Ireland.
Objectives:
To investigate how two major ciprofloxacin metabolites, 2-oxo ciprofloxacin (M3) and N-formyl ciprofloxacin (M4), influence the resistance profiles and biofilm characteristics of Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (ATCC 25923).
Methods:
Both metabolites were synthesised, structurally validated, and co-cultured with bacterial strains at subinhibitory concentrations over a 30-d period. Minimum inhibitory concentration (MIC) assays, crystal violet biofilm quantification, and genomic and transcriptomic analyses (whole-genome and differential RNA sequencing) were employed to assess phenotypic and molecular adaptations.
Results:
Exposure to ciprofloxacin metabolites altered bacterial behaviour despite their weak intrinsic antimicrobial activity. In S. aureus, continuous exposure to M3 and M4 resulted in an eight- and fourfold increase, respectively, in ciprofloxacin MIC values. In P. aeruginosa, although MIC values remained unchanged, prolonged exposure to both metabolites enhanced biofilm formation, M4 (P < 0.0001) and M3 (P < 0.0089). Genomic sequencing of P. aeruginosa revealed a missense mutation (A290D) in the wspA gene following M3 exposure, which activates biofilm-promoting pathways via cyclic-di-GMP signalling. RNA sequencing identified 220 differentially expressed genes, including upregulation of quorum-sensing regulators (rhlI, pqsH), nitric oxide cycle genes (nir, norCB), and the pel operon.
Conclusions:
Ciprofloxacin metabolites, though less potent than the parent antibiotic, can drive adaptive responses linked to resistance and persistence. Their capacity to induce stable genetic and transcriptomic shifts underscores their potential ecological and clinical significance as underexplored factors in antimicrobial resistance.
Insights
Ciprofloxacin metabolites, 2-oxo ciprofloxacin (M3) and N-formyl ciprofloxacin (M4), drive bacterial adaptation. These metabolites promote antibiotic resistance and biofilm formation in bacteria, highlighting their clinical significance in antimicrobial resistance.
Area of Science:
- Microbiology
- Pharmacology
- Genomics
Background:
- Ciprofloxacin is a widely used antibiotic.
- Antibiotic metabolism can lead to the formation of active or inactive compounds.
- The impact of ciprofloxacin metabolites on bacterial adaptation remains largely unexplored.
Purpose of the Study:
- To investigate the influence of two major ciprofloxacin metabolites, 2-oxo ciprofloxacin (M3) and N-formyl ciprofloxacin (M4), on the resistance profiles and biofilm characteristics of *Pseudomonas aeruginosa* and *Staphylococcus aureus*.
- To elucidate the molecular mechanisms underlying these adaptive responses.
Main Methods:
- Synthesis and structural validation of ciprofloxacin metabolites M3 and M4.
- Co-culture of bacterial strains (*P. aeruginosa* PAO1 and *S. aureus* ATCC 25923) with metabolites at sub-inhibitory concentrations (SICs) for 30 days.
- Phenotypic analysis using MIC assays and crystal violet biofilm quantification.
- Molecular analysis using whole genome and differential RNA sequencing.
Main Results:
- Exposure to M3 and M4 induced significant increases in ciprofloxacin Minimum Inhibitory Concentration (MIC) values in *S. aureus*.
- Prolonged exposure to M3 and M4 enhanced biofilm formation in *P. aeruginosa*.
- Genomic analysis of *P. aeruginosa* revealed a mutation in the *wspA* gene associated with M3 exposure, activating biofilm-promoting pathways.
- Transcriptomic analysis identified differential expression of genes involved in quorum sensing, nitric oxide metabolism, and biofilm formation.
Conclusions:
- Ciprofloxacin metabolites possess the capacity to induce adaptive responses in bacteria, contributing to antimicrobial resistance (AMR) and persistence.
- These metabolites can drive stable genetic and transcriptomic shifts, underscoring their potential ecological and clinical significance.
- The study highlights the importance of considering antibiotic metabolites as factors in AMR development.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing

